Contributing Member of the Healthcare Councils

Names and details of certain GLG News authors are available only to GLG Clients and Council Members. GLG News authors are subject-matter experts within the GLG Councils and are available for expert consulting - by phone, in-person, or written analysis. To find out how to become a GLG client or Council Member, click here.

GLG News by this Author

Analyses are solely the work of the authors and have not been edited or endorsed by GLG.

GLG News is now G+ Insights

G+ is a community for professionals, academics and entrepreneurs to connect through online discussions and in-person meetings. You will continue to see G+ Insights (formerly GLG News) here as well as on the G+ website, where you can share and discuss the G+ Insights you read.

Crossing the Blood Brain Barrier to Fight Glioma Tumors

November 26, 2009

Analysis of:Breaching a Barrier to Fight Brain Cancer | www.nytimes.com

Gliomas are malignant tumor in the human brain. Despite extensive research, prognosis for these patients is poor. One challenge/barrier that prevent chemotherapy agents from entering the brain is the "blood brain barrier." This barrier can be temporarily disrupted to allow passage of chemotherapy agents to enter the brain to fight the tumor. Microcatheters can be used during angiographic procedures to deliver chemotherapy. Avastin, manufactured by Genentech (DNA), is the drug being studied.

Expanding Treatment Options for Prostate Cancer

October 11, 2009

Analysis of:Medicare to cover controversial prostate treatment | www.philly.com

1. Medicare now covers Cyberknife radiosurgery treatment for prostate cancer in most parts of the United States.2. The Cyberknife has specific advantages over conventional surgery and conventional radiotherapy/IMRT for prostate cancer.3. Early clinical results on the use of Cyberknife radiosurgery for prostate cancer have been very favorable, with high rates of tumor control and minimal side effects.

Page : 11 to 2 of 2

Subscribe to Updates

By RSS